ONCOCIDIN

Serial Number 75263528
606

Registration Progress

Application Filed
Mar 25, 1997
Under Examination
Feb 17, 1998
Approved for Publication
Oct 24, 1997
Published for Opposition
Nov 25, 1997
Registered

Trademark Image

ONCOCIDIN

Basic Information

Serial Number
75263528
Filing Date
March 25, 1997
Published for Opposition
November 25, 1997
Abandonment Date
February 18, 2001
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 18, 2001
Classes
005

Rights Holder

BIOSOURCE TECHNOLOGIES, INC.

03
Address
3333 Vaca Valley Parkway
Vacaville, CA 95688

Ownership History

BIOSOURCE TECHNOLOGIES, INC.

Original Applicant
03
Vacaville, CA

BIOSOURCE TECHNOLOGIES, INC.

Owner at Publication
03
Vacaville, CA

Legal Representation

Attorney
DANIEL R GROPPER, ESQ

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Dec 29, 2000 REIN O REINSTATED Loading...
Dec 29, 2000 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 19, 2000 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 19, 2000 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 11, 2000 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 10, 2000 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 27, 1999 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 11, 1999 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 11, 1999 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 22, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 2, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 24, 1998 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 7, 1998 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 17, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 25, 1997 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 24, 1997 NPUB O NOTICE OF PUBLICATION Loading...
Sep 29, 1997 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 29, 1997 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cancer; active immunotherapy, including vaccines for the prevention and treatment of cancer; and passive immunotherapy for the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005